DescriptionFennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.
Stock Reports +
Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 12.24 unch no change |
| 15.62 -21.64% decrease |
| -2.05 (-14.35%) decrease |
|3-Month|| 12.24 unch no change |
| 17.25 -29.04% decrease |
| -5.11 (-29.45%) decrease |
|52-Week|| 7.10 +72.39% increase |
| 18.86 -35.10% decrease |
| +3.45 (+39.25%) increase |